187 related articles for article (PubMed ID: 2133215)
1. Therapeutic defibrinogenation by ancrod: effect on limb blood flow in peripheral vascular disease.
Wiles PG; Nelson SR; Hampton KK; Casali B; Boothby M; Prentice CR
Blood Coagul Fibrinolysis; 1990 Oct; 1(4-5):385-8. PubMed ID: 2133215
[TBL] [Abstract][Full Text] [Related]
2. Subcutaneous ancrod therapy in peripheral arterial disease: improvement in blood viscosity and nutritional blood flow.
Lowe GD; Morrice JJ; Forbes CD; Prentice CR; Fulton AJ; Barbenel JC
Angiology; 1979 Sep; 30(9):594-9. PubMed ID: 484913
[TBL] [Abstract][Full Text] [Related]
3. The effects of ancrod, the coagulating enzyme from the venom of Malayan pit viper (A. rhodostoma) on prothrombin and fibrinogen metabolism and fibrinopeptide A release in man.
Bell WR; Shapiro SS; Martinez J; Nossel HL
J Lab Clin Med; 1978 Apr; 91(4):592-604. PubMed ID: 641385
[TBL] [Abstract][Full Text] [Related]
4. The importance of plasma fibrinogen in vascular surgery.
Postlethwaite JC
Ann R Coll Surg Engl; 1976 Nov; 58(6):457-64. PubMed ID: 984690
[TBL] [Abstract][Full Text] [Related]
5. The fibrinolytic response to ancrod therapy: characterization of fibrinogen and fibrin degradation products.
Prentice CR; Hampton KK; Grant PJ; Nelson SR; Nieuwenhuizen W; Gaffney PJ
Br J Haematol; 1993 Feb; 83(2):276-81. PubMed ID: 8457476
[TBL] [Abstract][Full Text] [Related]
6. Subcutaneous ancrod after operation for fractured hip--a dose-ranging and feasibility study.
Lowe GD; Morrice JJ; Fulton A; Forbes CD; Prentice CR; Barbenel JC
Thromb Haemost; 1978 Aug; 40(1):134-43. PubMed ID: 725844
[TBL] [Abstract][Full Text] [Related]
7. Trial of a novel prostacyclin analog, UT-15, in patients with severe intermittent claudication.
Mohler ER; Klugherz B; Goldman R; Kimmel SE; Wade M; Sehgal CM
Vasc Med; 2000; 5(4):231-7. PubMed ID: 11213235
[TBL] [Abstract][Full Text] [Related]
8. Ancrod: clinical indications and methods of use.
Wright JG; Geroulakos G
Semin Vasc Surg; 1996 Dec; 9(4):315-28. PubMed ID: 8958608
[No Abstract] [Full Text] [Related]
9. Treatment of severe intermittent claudication by controlled defibrination.
Dormandy JA; Goyle KB; Reid HL
Lancet; 1977 Mar; 1(8012):625-6. PubMed ID: 66429
[TBL] [Abstract][Full Text] [Related]
10. Therapeutic defibrinogenation in peripheral vascular disease.
Ernst E
Int Angiol; 1985; 4(3):373-7. PubMed ID: 3913715
[TBL] [Abstract][Full Text] [Related]
11. Behavior of calf blood flow in normal subjects and in patients with intermittent claudication during a 24-h time span.
Bartoli V; Dorigo B; Tedeschi E; Biti G; Voegelin MR
Chronobiologia; 1975; 2(1):13-9. PubMed ID: 1192904
[TBL] [Abstract][Full Text] [Related]
12. Ancrod.
Sherman DG
Curr Med Res Opin; 2002; 18 Suppl 2():s48-52. PubMed ID: 12365829
[TBL] [Abstract][Full Text] [Related]
13. Fibrinolysis in glomerulonephritis treated with ancrod: renal functional, immunologic and histopathologic effects.
Kim S; Wadhwa NK; Kant KS; Pollak VE; Glas-Greenwalt P; Weiss MA; Hong CG
Q J Med; 1988 Nov; 69(259):879-905. PubMed ID: 3078212
[TBL] [Abstract][Full Text] [Related]
14. Beta blockade and intermittent claudication.
Lepäntalo M
Acta Med Scand Suppl; 1985; 700():1-48. PubMed ID: 2865873
[TBL] [Abstract][Full Text] [Related]
15. Segmental blood flow and rheological determinants in diabetic patients with peripheral occlusive arterial disease.
Vigilance JE; Reid HL
J Diabetes Complications; 2008; 22(3):210-6. PubMed ID: 18413225
[TBL] [Abstract][Full Text] [Related]
16. Defibrinogenating enzymes.
Bell WR
Drugs; 1997; 54 Suppl 3():18-30; discussion 30-1. PubMed ID: 9360849
[TBL] [Abstract][Full Text] [Related]
17. Studies on haematocrit in peripheral arterial disease.
Lowe GD; Saniabadi A; Turner A; Lieberman P; Pollock J; Drury J
Klin Wochenschr; 1986 Oct; 64(19):969-74. PubMed ID: 3784449
[TBL] [Abstract][Full Text] [Related]
18. Prostaglandin therapy of peripheral occlusive arterial disease.
Linhart J
Sb Lek; 1998; 99(4):355-62. PubMed ID: 10803275
[TBL] [Abstract][Full Text] [Related]
19. Ancrod: normalization of fibrinolytic enzyme abnormalities in patients with systemic lupus erythematosus and lupus nephritis.
Glas-Greenwalt P; Kant KS; Dosekun A; Frazier J; Allen C; Pollak VE
J Lab Clin Med; 1985 Jan; 105(1):99-107. PubMed ID: 3871465
[TBL] [Abstract][Full Text] [Related]
20. Peripheral sympathetic autoregulation in arterial calf inflow enhancement with intermittent pneumatic compression.
Delis KT; Nicolaides AN; Wolfe JH
Eur J Vasc Endovasc Surg; 2001 Oct; 22(4):317-25. PubMed ID: 11563890
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
